📂 Drugs
dostarlimab — Definition
dostarlimab / dostarlimab
Dostarlimab is a human monochlonal antibody that targets PD-1 receptor and is classified as immunocontrol point inhibitor. This drug is used in the treatment of endometrial cancer and other solid tumors, especially by increasing the activity of immune system against cancer cells. Dostarlimab prevents tumor cells from immune system by blocking PD-1 receptor in T cells and strengthens antitumor immuno response. In clinical practice, it is usually applied through intravenous infusion in patients who have advanced or recurrent disease and do not respond to standard therapies.
Frequently Asked Questions
❓ What is dostarlimab?
dostarlimab; dostarlimab is a human monochlonal antibody that targets PD-1 receptor and is classified as immunocontrol point inhibitor. This drug is used in the treatment of endometrial cancer and other solid tumors, especially by increasing the activity of immune system against cancer cells. Dostarlimab prevents tumor cells from immune system by blocking PD-1 receptor in T cells and strengthens antitumor immuno response. In clinical practice, it is usually applied through intravenous infusion in patients who have advanced or recurrent disease and do not respond to standard therapies.
❓ What is dostarlimab in Turkish?
The Turkish equivalent of "dostarlimab" is dostarlimab.
❓ Which medical field is dostarlimab related to?
This term belongs to the Drugs category.